Torrent Pharma Slapped Rs 60.28 Lakh NPPA Notice for Alleged Overcharging
New Delhi: Torrent Pharmaceuticals Limited has announced that it has received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) imposing a penalty of Rs 60.28 lakh under the provisions of the Drug Price Control Order (DPCO) 2013 for alleged overcharging on two of its drug products.
In a regulatory filing dated 30th September 2025, the company stated that the demand notice, dated 24th September 2025, was issued by NPPA’s office in New Delhi and received by Torrent on 29th September 2025. The notice was issued under Para 15 of the DPCO 2013, which authorizes the authority to recover overcharged amounts from pharmaceutical manufacturers found selling scheduled drugs above government-fixed ceiling prices.
According to the company’s disclosure, the NPPA’s action pertains to alleged overcharging for two drugs during the periods May 2018 to July 2020 and August 2023, respectively. Torrent Pharma further clarified that after its internal review, it does not expect any material impact on its financials, operations, or other activities due to this notice.
Torrent Pharmaceuticals, headquartered in Ahmedabad, is a drug manufacturer known for its presence across therapeutic areas including cardiovascular, central nervous system, gastrointestinal, and anti-infective segments. The company has maintained that it will assess the notice appropriately while ensuring full regulatory compliance.
The communication was signed by Chintan M. Trivedi, Company Secretary of Torrent Pharmaceuticals Limited, and disclosed to both the stock exchanges in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
